scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Gujarat Themis Biosyn Ltd

Feedback
Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd (GUJTHEMIS) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 387,109
Mar 28, 2025 00:00 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹281.91
₹-14.39 (-4.86%)
₹277 Low
Today’s Performance
₹298 High
₹208 Low
52 Week’s Performance
₹300.62 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -4.86%
  • 1 Week 10.84%
  • 1 Month 28.78%
  • 3 Months 15.79%
  • 6 Months 0.00%
  • 1 Year 0.00%
  • 3 Years 0.00%
  • 5 Years 0.00%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 1.00
  • Beta -452.98
  • 52-Week Low (₹) 208.00
  • 52-Week High (₹) 300.62
  • Price-to-Book (X)* 13.73
  • Dividend Yield (%) 0.24
  • Price-to-Earnings (P/E) (X)* 58.28
  • Earnings Per Share (₹) 4.83
  • Sector Price Earning (X)* 33.88
  • Market Cap (₹ Cr.)* 3,071.84
  • * Vaues as of last close price

COMPETITORS

BT TV

Chinese EV Giant BYD Takes Lead Over Tesla With Higher Sales, Growth & Stronger Market Presence 4:09 Chinese EV Giant BYD Takes Lead Over Tesla With Higher Sales, Growth & Stronger Market Presence
What To Avoid In FY26: Mayuresh Joshi's Investment Warnings! 1:00 What To Avoid In FY26: Mayuresh Joshi's Investment Warnings!
Becquer Solar Is Innovating With New-Age Materials To Enhance The Viability Of Solar Energy 5:22 Becquer Solar Is Innovating With New-Age Materials To Enhance The Viability Of Solar Energy
Smart Investing In FY26: How To Build A Balanced Portfolio With Large & Midcap Stocks 1:09 Smart Investing In FY26: How To Build A Balanced Portfolio With Large & Midcap Stocks
Anand Lakshmana Highlights the crucial role of technology in boosting workplace productivity and efficiency amidst rapid digital transformation across industries 4:40 Anand Lakshmana Highlights Crucial Role Of Technology In Boosting Workplace Productivity
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Dec 27, 2023 PURCHASE
MC JAIN INFOSERVICES PRIVATE LIMITED
  • Qty 490000
  • Average Price ₹215.00
Dec 27, 2023 Sell
PHARMACEUTICAL BUSINESS GROUP I LTD
  • Qty 3000000
  • Average Price ₹215.35
Apr 21, 2017 Sell
NEELKAMAL MOTILAL PAREKH
  • Qty 75000
  • Average Price ₹50.19
Apr 21, 2017 Sell
NEELKAMAL MOTILAL PAREKH
  • Qty 75000
  • Average Price ₹50.19
Apr 21, 2017 PURCHASE
MANJU PAREKH
  • Qty 75000
  • Average Price ₹50.19
Apr 21, 2017 PURCHASE
MANJU PAREKH
  • Qty 75000
  • Average Price ₹50.19
Mar 16, 2015 Sell
PRABHAT PRABHAT
  • Qty 93773
  • Average Price ₹38.26
Mar 16, 2015 PURCHASE
PRABHAT PRABHAT
  • Qty 22316
  • Average Price ₹39.31
Mar 16, 2015 Sell
PRABHAT PRABHAT
  • Qty 93773
  • Average Price ₹38.26
Mar 16, 2015 PURCHASE
PRABHAT PRABHAT
  • Qty 22316
  • Average Price ₹39.31
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Gujarat Themis Biosyn Ltd share price previously?
Gujarat Themis Biosyn Ltd share price was down by -4.86% from the previous closing price of ₹296.30.
Who are peers of Gujarat Themis Biosyn Ltd?
The peers of Gujarat Themis Biosyn Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd.
Who is/are the promoter/promoters of Gujarat Themis Biosyn Ltd?
The promotor/promotors of Gujarat Themis Biosyn Ltd are Dinesh S Patel, Sachin D Patel, VIJAY GOPI KISHAN AGARWAL, Kirandeep Madan, Siddharth Y Kusumgar, RAHUL DWARAKA SONI, Hitesh Dharmasinh Gajaria.
What has been 52-week high of Gujarat Themis Biosyn Ltd stocks?
The highest price of Gujarat Themis Biosyn Ltd stock is ₹300.62 in the last 52-week.
What is the share price of Gujarat Themis Biosyn Ltd (GUJTHEMIS) today on NSE?
As on Mar 28, 2025, Gujarat Themis Biosyn Ltd (GUJTHEMIS)’s share price on NSE is Rs 281.91
What is the market cap of Gujarat Themis Biosyn Ltd (GUJTHEMIS?)
The current market capitalisation of Gujarat Themis Biosyn Ltd (GUJTHEMIS) is 3,071.84 crores
What is Gujarat Themis Biosyn Ltd Share symbol?
The symbol of Gujarat Themis Biosyn Ltd is GUJTHEMIS.
What is the PE ratio of Gujarat Themis Biosyn Ltd (GUJTHEMIS)?
The current PE ratio of Gujarat Themis Biosyn Ltd (GUJTHEMIS) is 58.28.
What is the PB ratio of Gujarat Themis Biosyn Ltd (GUJTHEMIS)?
The current PB ratio of Gujarat Themis Biosyn Ltd (GUJTHEMIS) is 13.73.
Today’s High & Low share prices of Gujarat Themis Biosyn Ltd (GUJTHEMIS) on NSE?
Today, the share price of Gujarat Themis Biosyn Ltd (GUJTHEMIS) on NSE touched a high of Rs 298 and a low of Rs 277
What price did Gujarat Themis Biosyn Ltd (GUJTHEMIS) shares open on the NSE today?
On NSE, the share price of Gujarat Themis Biosyn Ltd (GUJTHEMIS) opened at Rs 291.85
What is the 52-week high of Gujarat Themis Biosyn Ltd (GUJTHEMIS)?
The 52-week high price of Gujarat Themis Biosyn Ltd (GUJTHEMIS) is Rs 300.62
What is the 52-week low of Gujarat Themis Biosyn Ltd (GUJTHEMIS) ?
The 52-week low price of Gujarat Themis Biosyn Ltd (GUJTHEMIS) is Rs 208

ABOUT GUJ. THEMIS BIO.

Gujarat Themis Biosyn Ltd, incorporated in the year 1981, has its registered office in 69/C GIDC Industrial Estate, Valsad Dist, VAPI, Gujarat, 396195, 91-260-2430027, 91-260-2400639. The main industry in which Gujarat Themis Biosyn Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Gujarat Themis Biosyn Ltd is/are GMJ & Co. In the main management, Dinesh S Patel is chairman and RAHUL DWARAKA SONI is the company secretary for Gujarat Themis Biosyn Ltd.

  • DSP Dinesh S Patel Chairman & Non Executive Dir.
  • SDP Sachin D Patel Non Executive Director
  • VGKA VIJAY GOPI KISHAN AGARWAL Independent Non Exe. Director
  • KM Kirandeep Madan Independent Non Exe. Director
  • SYK Siddharth Y Kusumgar Independent Non Exe. Director
  • RDS RAHUL DWARAKA SONI Company Sec. & Compli. Officer
  • HDG Hitesh Dharmasinh Gajaria Independent Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement